US Supreme Court rejects blood monitoring patents
Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine.
The Supreme Court rejected two patents covering medical tests for monitoring patients' blood, saying they are too similar to natural phenomena to receive intellectual property protection.
The patents were held by Prometheus Laboratories, a subsidiary of Swiss food maker Nestle.
The unanimous Supreme Court decision said, "Laws of nature, natural phenomena and abstract ideas are not patentable" under provisions of the US Patent Act.
To be covered by a patent, "an application of a law of nature... must do more than simply state the law of nature while adding the words 'apply it.' It must limit its reach to a particular, inventive application of the law," said the decision written by Justice Stephen Breyer.
"The claims are consequently invalid," said the court's decision, which reversed an earlier ruling of the US Court of Appeals for the Federal Circuit.
The patents covered a method developed by Prometheus Laboratory for adjusting dosages of thiopurine treatment for patients with immune system diseases, such as Crohn's disease, a chronic intestinal inflammation.
The dosages must be adjusted precisely to ensure the drug is effective and avoids side effects.
The Supreme Court said the Prometheus patents merely followed natural laws by establishing a link between levels of certain chemicals in the blood and too high or insufficient dosages of thiopurine.
Officials from the $4 billion a year biotechnoloy industry say the court's decision could remove incentives for development of other personalized medicine devices.
"It's a major shift and will have a profound effects on personalized medicine," said Michael Samardzija, a lawyer specializing in intellectual property for the law firm of Bracewell and Giuliani.
The ruling will make it "a lot more difficult" for diagnostic test makers to claim their new products are eligible for patents, Samardzija told The Wall Street Journal.
(c) 2012 AFP
-
Court rules against inventors in patent case
Jun 28, 2010 |
not rated yet |
0
-
Court Denies Vonage Bid for Patent Case Retrial
May 04, 2007 |
not rated yet |
0
-
US court hears appeal in key gene patent case
Apr 04, 2011 |
not rated yet |
0
-
US Supreme Court hears Microsoft case on patents
Apr 19, 2011 |
not rated yet |
0
-
Microsoft request for patent suit review is nixed
Apr 01, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Flesh-eating disease victim gets prosthetic hands
(AP)—A woman who lost both hands, her left leg and right foot after contracting a flesh-eating disease has been fitted with prosthetic hands.
Other
May 18, 2013 |
not rated yet |
0
Illinois Senate approves medical marijuana bill
(AP)—Medical marijuana use in Illinois is now in Gov. Pat Quinn's hands after the state Senate approved legislation.
Other
May 17, 2013 |
5 / 5 (1) |
0
Nigerian court jails two over killer teething drug
A Nigerian court on Friday sentenced two officials from a pharmaceutical company to seven years in prison over the sale of an adulterated teething drug which killed 84 babies in 2008.
Other
May 17, 2013 |
not rated yet |
0
Many patients would switch doc to cut health care costs
(HealthDay)—Many Americans feel that keeping out-of-pocket health care costs is more important than staying with the same primary care physician.
Other
May 17, 2013 |
not rated yet |
0
Cultural attitudes impede organ donations in China
(AP)—China is phasing out its reliance on executed prisoners for donated organs, but an architect of the country's transplant system said Friday that ingrained cultural attitudes are impeding the rise of ...
Other
May 17, 2013 |
not rated yet |
0
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Ginger compounds may be effective in treating asthma symptoms
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
Mar 22, 2012
Rank: not rated yet
NOT REAL ONES! YOU need to read the ruling again AND the Supreme Court is bumping into the area of the patent environment that has needed closer scrutiny and a total rewrite for a LONG time. They are saying, stuff that is derived from a known biological process MUST address specific aspects of remedial or preventive care other than the fact and need of remedial or preventable disease dialog. 'What makes this 'cure' any different than known naturally occurring biological processes?! The answer to that question is made more complicated by the intrinsic inclusion of a biological process, a process that may itself be contributing to the ailment or condition (genes), as opposed to, as we have done it for 8000 years, INTRODUCING a biological or chemical agent that assists or constitutes a remedy or palliative.
word-